 | • レポートコード：QY2108PAL8919 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおけるポリオワクチンの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、ポリオワクチンの種類別市場規模（不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV））、用途別市場規模（公共用、個人用）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のポリオワクチン市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるポリオワクチンの種類別市場規模（2016年-2027年）：不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV） ・世界におけるポリオワクチンの用途別市場規模（2016年-2027年）：公共用、個人用 ・ポリオワクチンの中国市場分析 - ポリオワクチンの中国市場規模（2016年-2027年） - 中国におけるポリオワクチンの主要プレイヤー別市場シェア - 中国におけるポリオワクチンの種類別市場規模：不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV） - 中国におけるポリオワクチンの用途別市場規模：公共用、個人用 ・ポリオワクチンの北米市場（2016年-2027年） ・ポリオワクチンのヨーロッパ市場（2016年-2027年） ・ポリオワクチンのアジア太平洋市場（2016年-2027年） ・ポリオワクチンの中南米市場（2016年-2027年） ・ポリオワクチンの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Sanofi、GSK、Bibcol、Serum Institute、Tiantan Biological、IMBCA、Panacea Biotec Ltd、Bio-Med、Halfkin Bio-Pharmaceuticals ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 91% market shares.
Market Analysis and Insights: Global and China Polio Vaccine Market
This report focuses on global and China Polio Vaccine market.
In 2020, the global Polio Vaccine market size was US$ 669.5 million and it is expected to reach US$ 906.5 million by the end of 2027, with a CAGR of 4.2% during 2021-2027. In China the Polio Vaccine market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Polio Vaccine Scope and Market Size
Polio Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Polio Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Polio Vaccine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Segment by Application
Public
Private
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
1 Study Coverage
1.1 Polio Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Polio Vaccine Market Size Growth Rate by Type
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Market by Application
1.3.1 Global Polio Vaccine Market Size Growth Rate by Application
1.3.2 Public
1.3.3 Private
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Polio Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Polio Vaccine Revenue 2016-2027
2.1.2 Global Polio Vaccine Sales 2016-2027
2.2 Global Polio Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Polio Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Polio Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Polio Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Polio Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Polio Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Polio Vaccine Revenue Forecast by Region (2022-2027)
3 Global Polio Vaccine Competitor Landscape by Players
3.1 Global Top Polio Vaccine Manufacturers by Sales
3.1.1 Global Polio Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Polio Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Polio Vaccine Manufacturers by Revenue
3.2.1 Key Polio Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Polio Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Polio Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Polio Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Polio Vaccine Revenue in 2020
3.2.6 Global Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Polio Vaccine Price by Manufacturers
3.4 Global Polio Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Polio Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Polio Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Polio Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Polio Vaccine Market Size by Type (2016-2021)
4.1.1 Global Polio Vaccine Sales by Type (2016-2021)
4.1.2 Global Polio Vaccine Revenue by Type (2016-2021)
4.1.3 Polio Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Polio Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Polio Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Polio Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Polio Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Polio Vaccine Market Size by Application (2016-2021)
5.1.1 Global Polio Vaccine Sales by Application (2016-2021)
5.1.2 Global Polio Vaccine Revenue by Application (2016-2021)
5.1.3 Polio Vaccine Price by Application (2016-2021)
5.2 Polio Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Polio Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Polio Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Polio Vaccine Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Polio Vaccine Market Size YoY Growth 2016-2027
6.1.1 China Polio Vaccine Sales YoY Growth 2016-2027
6.1.2 China Polio Vaccine Revenue YoY Growth 2016-2027
6.1.3 China Polio Vaccine Market Share in Global Market 2016-2027
6.2 China Polio Vaccine Market Size by Players (International and Local Players)
6.2.1 China Top Polio Vaccine Players by Sales (2016-2021)
6.2.2 China Top Polio Vaccine Players by Revenue (2016-2021)
6.3 China Polio Vaccine Historic Market Review by Type (2016-2021)
6.3.1 China Polio Vaccine Sales Market Share by Type (2016-2021)
6.3.2 China Polio Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 China Polio Vaccine Price by Type (2016-2021)
6.4 China Polio Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Polio Vaccine Sales Forecast by Type (2022-2027)
6.4.2 China Polio Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 China Polio Vaccine Price Forecast by Type (2022-2027)
6.5 China Polio Vaccine Historic Market Review by Application (2016-2021)
6.5.1 China Polio Vaccine Sales Market Share by Application (2016-2021)
6.5.2 China Polio Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 China Polio Vaccine Price by Application (2016-2021)
6.6 China Polio Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Polio Vaccine Sales Forecast by Application (2022-2027)
6.6.2 China Polio Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 China Polio Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Polio Vaccine Market Size YoY Growth 2016-2027
7.2 North America Polio Vaccine Market Facts & Figures by Country
7.2.1 North America Polio Vaccine Sales by Country (2016-2021)
7.2.2 North America Polio Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Polio Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Polio Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Polio Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Polio Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Polio Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Polio Vaccine Market Facts & Figures by Country
9.2.1 Europe Polio Vaccine Sales by Country (2016-2021)
9.2.2 Europe Polio Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Polio Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Polio Vaccine Market Facts & Figures by Country
10.2.1 Latin America Polio Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Polio Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Polio Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Polio Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Polio Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Polio Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Description and Business Overview
12.1.3 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi Polio Vaccine Products Offered
12.1.5 Sanofi Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Description and Business Overview
12.2.3 GSK Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Polio Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 Bibcol
12.3.1 Bibcol Corporation Information
12.3.2 Bibcol Description and Business Overview
12.3.3 Bibcol Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bibcol Polio Vaccine Products Offered
12.3.5 Bibcol Recent Development
12.4 Serum Institute
12.4.1 Serum Institute Corporation Information
12.4.2 Serum Institute Description and Business Overview
12.4.3 Serum Institute Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Serum Institute Polio Vaccine Products Offered
12.4.5 Serum Institute Recent Development
12.5 Tiantan Biological
12.5.1 Tiantan Biological Corporation Information
12.5.2 Tiantan Biological Description and Business Overview
12.5.3 Tiantan Biological Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Tiantan Biological Polio Vaccine Products Offered
12.5.5 Tiantan Biological Recent Development
12.6 IMBCA
12.6.1 IMBCA Corporation Information
12.6.2 IMBCA Description and Business Overview
12.6.3 IMBCA Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 IMBCA Polio Vaccine Products Offered
12.6.5 IMBCA Recent Development
12.7 Panacea Biotec Ltd
12.7.1 Panacea Biotec Ltd Corporation Information
12.7.2 Panacea Biotec Ltd Description and Business Overview
12.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Panacea Biotec Ltd Polio Vaccine Products Offered
12.7.5 Panacea Biotec Ltd Recent Development
12.8 Bio-Med
12.8.1 Bio-Med Corporation Information
12.8.2 Bio-Med Description and Business Overview
12.8.3 Bio-Med Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bio-Med Polio Vaccine Products Offered
12.8.5 Bio-Med Recent Development
12.9 Halfkin Bio-Pharmaceuticals
12.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
12.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
12.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Products Offered
12.9.5 Halfkin Bio-Pharmaceuticals Recent Development
12.11 Sanofi
12.11.1 Sanofi Corporation Information
12.11.2 Sanofi Description and Business Overview
12.11.3 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sanofi Polio Vaccine Products Offered
12.11.5 Sanofi Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Polio Vaccine Industry Trends
13.2 Polio Vaccine Market Drivers
13.3 Polio Vaccine Market Challenges
13.4 Polio Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Polio Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Polio Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Inactivated Polio Vaccine (IPV)
Table 3. Major Manufacturers of Oral Polio Vaccine (OPV)
Table 4. Global Polio Vaccine Market Size Growth Rate by Application (2021-2027) & (M Doses)
Table 5. Global Polio Vaccine Market Size by Region (M Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Polio Vaccine Sales by Regions (2016-2021) & (M Doses)
Table 7. Global Polio Vaccine Sales Market Share by Regions (2016-2021)
Table 8. Global Polio Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Polio Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
Table 10. Global Polio Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Polio Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Polio Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Polio Vaccine Sales by Manufacturers (2016-2021) (M Doses)
Table 14. Global Polio Vaccine Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Polio Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 16. Polio Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Polio Vaccine Revenue Share by Manufacturers (2016-2021)
Table 18. Global Polio Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Polio Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polio Vaccine as of 2020)
Table 20. Key Manufacturers Polio Vaccine Price (2016-2021) (USD/K Doses)
Table 21. Polio Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Polio Vaccine Product Type
Table 23. Date of International Manufacturers Enter into Polio Vaccine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Polio Vaccine Sales by Type (2016-2021) (M Doses)
Table 26. Global Polio Vaccine Sales Share by Type (2016-2021)
Table 27. Global Polio Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Polio Vaccine Revenue Share by Type (2016-2021)
Table 29. Polio Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/K Doses)
Table 30. Global Polio Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
Table 31. Global Polio Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Polio Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Polio Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Polio Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/K Doses)
Table 35. Global Polio Vaccine Sales by Application (2016-2021) (M Doses)
Table 36. Global Polio Vaccine Sales Share by Application (2016-2021)
Table 37. Global Polio Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Polio Vaccine Revenue Share by Application (2016-2021)
Table 39. Polio Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/K Doses)
Table 40. Global Polio Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
Table 41. Global Polio Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Polio Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Polio Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Polio Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/K Doses)
Table 45. China Polio Vaccine Sales (M Doses) of Key Companies (2016-2021)
Table 46. China Polio Vaccine Sales Share by Company (2016-2021)
Table 47. China Polio Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 48. China Polio Vaccine Revenue Share by Company (2016-2021)
Table 49. China Polio Vaccine Sales (M Doses) by Type (2016-2021)
Table 50. China Polio Vaccine Sales Share by Type (2016-2021)
Table 51. China Polio Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Polio Vaccine Price (USD/K Doses) by Type (2016-2021)
Table 53. China Polio Vaccine Sales (M Doses) by Type (2022-2027)
Table 54. China Polio Vaccine Sales Share by Type (2022-2027)
Table 55. China Polio Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Polio Vaccine Revenue Share by Type (2022-2027)
Table 57. China Polio Vaccine Price (USD/K Doses) by Type (2022-2027)
Table 58. China Polio Vaccine Sales (M Doses) by Application (2016-2021)
Table 59. China Polio Vaccine Sales Share by Application (2016-2021)
Table 60. China Polio Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Polio Vaccine Price (USD/K Doses) by Application (2016-2021)
Table 62. China Polio Vaccine Sales (M Doses) by Application (2022-2027)
Table 63. China Polio Vaccine Sales Share by Application (2022-2027)
Table 64. China Polio Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Polio Vaccine Revenue Share by Application (2022-2027)
Table 66. China Polio Vaccine Price (USD/K Doses) by Application (2022-2027)
Table 67. North America Polio Vaccine Sales by Country (2016-2021) & (M Doses)
Table 68. North America Polio Vaccine Sales Market Share by Country (2016-2021)
Table 69. North America Polio Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Polio Vaccine Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Polio Vaccine Sales by Region (2016-2021) & (M Doses)
Table 72. Asia Pacific Polio Vaccine Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Polio Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Polio Vaccine Revenue Market Share by Region (2016-2021)
Table 75. Europe Polio Vaccine Sales by Country (2016-2021) & (M Doses)
Table 76. Europe Polio Vaccine Sales Market Share by Country (2016-2021)
Table 77. Europe Polio Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Polio Vaccine Revenue Market Share by Country (2016-2021)
Table 79. Latin America Polio Vaccine Sales by Country (2016-2021) & (M Doses)
Table 80. Latin America Polio Vaccine Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Polio Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Polio Vaccine Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Polio Vaccine Sales by Country (2016-2021) & (M Doses)
Table 84. Middle East and Africa Polio Vaccine Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Polio Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Polio Vaccine Revenue Market Share by Country (2016-2021)
Table 87. Sanofi Corporation Information
Table 88. Sanofi Description and Business Overview
Table 89. Sanofi Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 90. Sanofi Polio Vaccine Product
Table 91. Sanofi Recent Development
Table 92. GSK Corporation Information
Table 93. GSK Description and Business Overview
Table 94. GSK Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 95. GSK Product
Table 96. GSK Recent Development
Table 97. Bibcol Corporation Information
Table 98. Bibcol Description and Business Overview
Table 99. Bibcol Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 100. Bibcol Product
Table 101. Bibcol Recent Development
Table 102. Serum Institute Corporation Information
Table 103. Serum Institute Description and Business Overview
Table 104. Serum Institute Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 105. Serum Institute Product
Table 106. Serum Institute Recent Development
Table 107. Tiantan Biological Corporation Information
Table 108. Tiantan Biological Description and Business Overview
Table 109. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 110. Tiantan Biological Product
Table 111. Tiantan Biological Recent Development
Table 112. IMBCA Corporation Information
Table 113. IMBCA Description and Business Overview
Table 114. IMBCA Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 115. IMBCA Product
Table 116. IMBCA Recent Development
Table 117. Panacea Biotec Ltd Corporation Information
Table 118. Panacea Biotec Ltd Description and Business Overview
Table 119. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 120. Panacea Biotec Ltd Product
Table 121. Panacea Biotec Ltd Recent Development
Table 122. Bio-Med Corporation Information
Table 123. Bio-Med Description and Business Overview
Table 124. Bio-Med Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 125. Bio-Med Product
Table 126. Bio-Med Recent Development
Table 127. Halfkin Bio-Pharmaceuticals Corporation Information
Table 128. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 129. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 130. Halfkin Bio-Pharmaceuticals Product
Table 131. Halfkin Bio-Pharmaceuticals Recent Development
Table 132. Polio Vaccine Market Trends
Table 133. Polio Vaccine Market Drivers
Table 134. Polio Vaccine Market Challenges
Table 135. Polio Vaccine Market Restraints
Table 136. Polio Vaccine Customers List
Table 137. Polio Vaccine Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Polio Vaccine Product Picture
Figure 2. Global Polio Vaccine Sales Market Share by Type in 2020 & 2027
Figure 3. Inactivated Polio Vaccine (IPV) Product Picture
Figure 4. Oral Polio Vaccine (OPV) Product Picture
Figure 5. Global Polio Vaccine Sales Market Share by Application in 2020 & 2027
Figure 6. Public
Figure 7. Private
Figure 8. Polio Vaccine Report Years Considered
Figure 9. Global Polio Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Polio Vaccine Market Size 2016-2027 (US$ Million)
Figure 11. Global Polio Vaccine Sales 2016-2027 (M Doses)
Figure 12. Global Polio Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Polio Vaccine Sales Market Share by Region (2016-2021)
Figure 14. Global Polio Vaccine Sales Market Share by Region in 2020
Figure 15. Global Polio Vaccine Revenue Market Share by Region (2016-2021)
Figure 16. Global Polio Vaccine Revenue Market Share by Region in 2020
Figure 17. Global Polio Vaccine Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Polio Vaccine Revenue in 2020
Figure 19. Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Polio Vaccine Sales Market Share by Type (2016-2021)
Figure 21. Global Polio Vaccine Sales Market Share by Type in 2020
Figure 22. Global Polio Vaccine Revenue Market Share by Type (2016-2021)
Figure 23. Global Polio Vaccine Revenue Market Share by Type in 2020
Figure 24. Global Polio Vaccine Sales Market Share by Application (2016-2021)
Figure 25. Global Polio Vaccine Sales Market Share by Application in 2020
Figure 26. Global Polio Vaccine Revenue Market Share by Application (2016-2021)
Figure 27. Global Polio Vaccine Revenue Market Share by Application in 2020
Figure 28. China Polio Vaccine Sales Growth Rate 2016-2027 (M Doses)
Figure 29. China Polio Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. China Polio Vaccine Market Share in Global Market 2016-2027
Figure 31. China 5 and 10 Largest Polio Vaccine Players Market Share by Revenue in Polio Vaccine in 2020
Figure 32. China Polio Vaccine Revenue Share by Type (2016-2021)
Figure 33. China Polio Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 34. China Polio Vaccine Revenue Share by Application (2016-2021)
Figure 35. China Polio Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Polio Vaccine Sales Growth Rate 2016-2021 (M Doses)
Figure 37. North America Polio Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Polio Vaccine Sales Market Share by Country in 2020
Figure 39. North America Polio Vaccine Revenue Market Share by Country in 2020
Figure 40. U.S. Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 41. U.S. Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 43. Canada Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Polio Vaccine Sales Growth Rate 2016-2021 (M Doses)
Figure 45. Europe Polio Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Polio Vaccine Sales Market Share by Country in 2020
Figure 47. Europe Polio Vaccine Revenue Market Share by Country in 2020
Figure 48. Germany Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 49. Germany Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 51. France Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 53. U.K. Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 55. Italy Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 57. Russia Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Polio Vaccine Sales Growth Rate 2016-2021 (M Doses)
Figure 59. Asia Pacific Polio Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Polio Vaccine Sales Market Share by Region in 2020
Figure 61. Asia Pacific Polio Vaccine Revenue Market Share by Region in 2020
Figure 62. China Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 63. China Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 65. Japan Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 67. South Korea Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 69. India Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 71. Australia Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Taiwan Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 73. Taiwan Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 75. Indonesia Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 77. Thailand Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 79. Malaysia Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Philippines Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 81. Philippines Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Vietnam Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 83. Vietnam Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America Polio Vaccine Sales Growth Rate 2016-2021 (M Doses)
Figure 85. Latin America Polio Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America Polio Vaccine Sales Market Share by Country in 2020
Figure 87. Latin America Polio Vaccine Revenue Market Share by Country in 2020
Figure 88. Mexico Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 89. Mexico Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 91. Brazil Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 93. Argentina Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Middle East and Africa Polio Vaccine Sales Growth Rate 2016-2021 (M Doses)
Figure 95. Middle East and Africa Polio Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 96. Middle East and Africa Polio Vaccine Sales Market Share by Country in 2020
Figure 97. Middle East and Africa Polio Vaccine Revenue Market Share by Country in 2020
Figure 98. Turkey Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 99. Turkey Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Saudi Arabia Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 101. Saudi Arabia Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. U.A.E Polio Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 103. U.A.E Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Polio Vaccine Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed
ポリオワクチンの世界市場 2020年 Market Overview The Polio Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…- 経口ポリオワクチン（OPV）の世界市場 2020年 Market Overview The global Oral Polio Vaccines (OPV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Polio Vaccines…
- ワクチンの世界市場 2020年 Market Overview The Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 肺炎球菌ワクチンの世界及び中国市場 Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines. 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate …
- 点鼻ワクチンの世界及び中国市場 Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza. The FluMist is the only alternative to the flu shot without a needle and is given in the form of a nasal spray. Nasal Spray Vaccine is widely sales for Child and Adult The most proportion of Nasal …